Total Payments
$8,668
2024 Payments
$493.80
Companies
33
Transactions
181
Medicare Patients
3,120
Medicare Billing
$311,592
Payment Breakdown by Category
Other$4,875 (56.2%)
Food & Beverage$3,786 (43.7%)
Education$6.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $4,875 | 1 | 56.2% |
| Food and Beverage | $3,786 | 179 | 43.7% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $4,875 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $497.21 | 25 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $392.64 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $360.18 | 15 | $0 (2023) |
| Boston Scientific Corporation | $330.51 | 18 | $0 (2023) |
| Bard Peripheral Vascular, Inc. | $264.86 | 17 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $258.58 | 16 | $0 (2021) |
| Amarin Pharma Inc. | $240.42 | 3 | $0 (2019) |
| Merck Sharp & Dohme LLC | $157.74 | 8 | $0 (2022) |
| Cardiovascular Systems Inc. | $132.38 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $493.80 | 18 | Novartis Pharmaceuticals Corporation ($243.73) |
| 2023 | $172.16 | 10 | Novartis Pharmaceuticals Corporation ($130.87) |
| 2022 | $5,177 | 16 | AngioDynamics, Inc. ($4,875) |
| 2021 | $505.83 | 27 | Merck Sharp & Dohme Corporation ($88.66) |
| 2020 | $319.56 | 18 | Janssen Pharmaceuticals, Inc ($70.16) |
| 2019 | $676.76 | 31 | Janssen Pharmaceuticals, Inc ($137.32) |
| 2018 | $683.27 | 32 | AstraZeneca Pharmaceuticals LP ($115.01) |
| 2017 | $639.60 | 29 | E.R. Squibb & Sons, L.L.C. ($148.75) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 8 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/07/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2017 | Cardiovascular Systems Inc. | Peripheral Orbital Atherectomy System (Device) | Food and Beverage | Cash or cash equivalent | $23.87 | General |
| Category: Atherectomy Device | ||||||
| 01/28/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - ANGIOPLASTY (Device) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: ANGIOPLASTY | ||||||
| 01/26/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $118.90 | General |
| Category: Cardiovascular | ||||||
| 01/24/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiology | ||||||
| 01/17/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.76 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,249 | 1,992 | $493,869 | $139,535 |
| 2022 | 14 | 835 | 961 | $265,851 | $82,049 |
| 2021 | 6 | 479 | 581 | $152,582 | $42,134 |
| 2020 | 5 | 557 | 706 | $172,028 | $47,874 |
Total Patients
3,120
Total Services
4,240
Medicare Billing
$311,592
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 419 | 803 | $204,075 | $69,743 | 34.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 61 | 62 | $43,400 | $8,740 | 20.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $24,548 | $7,670 | 31.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 80 | 128 | $23,530 | $7,097 | 30.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 59 | 60 | $44,460 | $7,064 | 15.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 39 | 40 | $16,330 | $5,331 | 32.6% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 48 | 53 | $15,076 | $5,084 | 33.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 15 | 103 | $11,330 | $4,890 | 43.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 35 | $14,230 | $4,500 | 31.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 22 | 22 | $16,874 | $3,102 | 18.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 18 | 18 | $16,794 | $2,740 | 16.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 15 | 103 | $8,466 | $1,954 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 29 | $5,295 | $1,724 | 32.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 38 | 75 | $7,275 | $1,637 | 22.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 49 | 96 | $8,352 | $1,555 | 18.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 138 | 144 | $6,624 | $1,418 | 21.4% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 11 | 17 | $4,540 | $1,169 | 25.7% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 12 | 17 | $4,120 | $1,135 | 27.6% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 33 | 34 | $8,500 | $943.06 | 11.1% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 11 | 16 | $2,587 | $733.46 | 28.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 11 | 22 | $4,224 | $559.80 | 13.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 30 | 32 | $2,092 | $515.06 | 24.6% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 29 | 31 | $1,147 | $231.18 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 286 | 392 | $90,090 | $37,672 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 139 | $29,550 | $7,958 | 26.9% |
About Dr. Wallace Lai, MD
Dr. Wallace Lai, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578503249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wallace Lai, MD has received a total of $8,668 in payments from pharmaceutical and medical device companies, with $493.80 received in 2024. These payments were reported across 181 transactions from 33 companies. The most common payment nature is "Long term medical supply or device loan" ($4,875).
As a Medicare-enrolled provider, Lai has provided services to 3,120 Medicare beneficiaries, totaling 4,240 services with total Medicare billing of $311,592. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Location Salem, OR
- Active Since 06/08/2006
- Last Updated 09/01/2015
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1578503249
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $4,875
- XARELTO (Drug) $497.21
- ELIQUIS (Drug) $467.23
- LEQVIO (Drug) $247.84
- Vascepa (Drug) $240.42
- BRILINTA (Drug) $196.56
- VERQUVO (Drug) $157.74
- ENTRESTO (Drug) $144.80
- Peripheral Orbital Atherectomy System (Device) $132.38
- Repatha (Biological) $91.60
- FLUENCY (Device) $80.71
- CROSSER (Device) $66.60
- COYOTE (Device) $65.70
- FARXIGA (Drug) $62.02
- Optimizer (Device) $58.25
- INNOVA (Device) $58.15
- VENASEAL (Device) $47.75
- ENROUTE Transcarotid Neuroprotection System (Device) $45.00
- Rotarex (Device) $41.61
- LIFESTENT (Device) $34.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.